Tumor-Targeted Antibodies

Jan 14, 2018 by in ONCOLOGY Comments Off on Tumor-Targeted Antibodies

Fig. 18.1 Molecular structure of antibodies. Antibodies of the IgA, IgD, IgE, and IgG have two antigen-binding sites. IgA antibodies can be dimeric and IgM are pentameric. Monomeric antibodies have…

read more

Predictors of Response to Immune Checkpoint Blockade

Jan 14, 2018 by in ONCOLOGY Comments Off on Predictors of Response to Immune Checkpoint Blockade

Fig. 31.1 Hallmarks of response to immune checkpoint blockade. Identification of predictors of response to immune checkpoint hinges on an understanding of the influence of numerous factors on cancer development…

read more

Plasmacytoid DC/Regulatory T Cell Interactions at the Center of an Immunosuppressive Network in Breast and Ovarian Tumors

Jan 14, 2018 by in ONCOLOGY Comments Off on Plasmacytoid DC/Regulatory T Cell Interactions at the Center of an Immunosuppressive Network in Breast and Ovarian Tumors

Fig. 8.1 pDC plasticity. During viral infection and certain autoimmune diseases (Lupus, Psoriasis) pDCs contribute to immune response through TLR-7/9 engagement by viral or endogenous nucleic acid leading to their…

read more

Toward Engineered Cells as Transformational and Broadly Available Medicines for the Treatment of Cancer

Jan 14, 2018 by in ONCOLOGY Comments Off on Toward Engineered Cells as Transformational and Broadly Available Medicines for the Treatment of Cancer

Antigen Antigen class Phase Comment Alpha fetoprotein (αFP) Differentiation Preclinical  Carcinoembryonic antigen (CEA) Differentiation Ph1 Terminated—poor accrual Glycoprotein 100 (Gp100) Differentiation Ph2  Hepatitis B virus (HBV) antigen Viral antigen Ph1 …

read more

Oncolytic Viruses: T-VEC and Others

Jan 14, 2018 by in ONCOLOGY Comments Off on Oncolytic Viruses: T-VEC and Others

Fig. 24.1 Mechanism of action of oncolytic viruses: selective replication in cancer cells, tumor lysis, release of virus, and spread within cancer tissue (Reproduced from Kirn D et al. (2001)…

read more

Cancer Vaccines for HPV Malignancies

Jan 14, 2018 by in ONCOLOGY Comments Off on Cancer Vaccines for HPV Malignancies

Fig. 15.1 Global incidence of pathogen-induced human malignancies in 2012 [96] Fig. 15.2 Number of new HPV-associated cancers in 2009 [3] Exposure to HPV occurs with sexual debut and is…

read more
Get Clinical Tree app for offline access